Jennifer L. Good, Director at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 63,502 shares at $52.40 ($3.3M) on 2024-09-17, disclosed to the SEC on 2024-09-19.
Scheduled sale ($3.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.40 | 31,751 | $1.7M | 50.0% |
| 2 | $52.40 | 31,751 | $1.7M | 50.0% |
| Total | $52.40 avg | 63,502 | $3.3M | 100% |
| Filing → |
| TRVI | SELL | 2024-09-09 | $18K | — | Filing → |
| TRVI | SELL | 2024-09-05 | $295K | — | Filing → |
| RYTM | SELL | 2024-08-28 | $1.5M | — | Filing → |